Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
BrightSpring Health Services
BTSG
$12.4B
| $8.94M | ﹤0.01% |
494,231
+43,238
| +10% | +$849K |
|
2002
Coastal Financial
CCB
$693M
| $8.94M | ﹤0.01% |
98,858
+5,899
| +6% | +$516K |
|
|
SWI
2003
DELISTED
SolarWinds Corporation Common Stock
SWI
| $8.92M | ﹤0.01% |
484,173
+12,977
| +3% | +$218K |
|
2004
Vir Biotechnology
VIR
$1.49B
| $8.91M | ﹤0.01% |
1,374,874
+122,219
| +10% | +$1.09M |
|
|
DX
2005
Dynex Capital
DX
$3.21B
| $8.88M | ﹤0.01% |
682,364
+30,232
| +5% | +$405K |
|
|
PLYM
2006
DELISTED
Plymouth Industrial REIT
PLYM
| $8.88M | ﹤0.01% |
544,819
-114,385
| -17% | -$1.93M |
|
2007
United States Lime & Minerals
USLM
$3.44B
| $8.88M | ﹤0.01% |
100,474
+4,318
| +4% | +$449K |
|
|
OKLO
2008
Oklo
OKLO
$8.42B
| $8.88M | ﹤0.01% |
410,432
-11,999
| -3% | -$405K |
|
2009
Heartland Express
HTLD
$956M
| $8.84M | ﹤0.01% |
959,257
+60,968
| +7% | +$645K |
|
2010
Flywire
FLYW
$2.16B
| $8.82M | ﹤0.01% |
928,831
-16,781
| -2% | -$264K |
|
2011
CareDx
CDNA
$2.42B
| $8.82M | ﹤0.01% |
496,803
-15,119
| -3% | -$326K |
|
|
RWT
2012
Redwood Trust
RWT
$594M
| $8.79M | ﹤0.01% |
1,447,700
+36,547
| +3% | +$234K |
|
2013
MiMedx Group
MDXG
$633M
| $8.77M | ﹤0.01% |
1,153,597
-243,914
| -17% | -$2.04M |
|
|
PRO
2014
DELISTED
PROS Holdings
PRO
| $8.73M | ﹤0.01% |
458,899
+18,432
| +4% | +$430K |
|
|
AVNS
2015
DELISTED
Avanos Medical
AVNS
| $8.72M | ﹤0.01% |
608,635
+148,619
| +32% | +$2.32M |
|
2016
Bausch Health
BHC
$2.34B
| $8.7M | ﹤0.01% |
1,341,999
+57,963
| +5% | +$416K |
|
2017
Cimpress
CMPR
$2.31B
| $8.7M | ﹤0.01% |
192,293
-26,204
| -12% | -$1.47M |
|
2018
Eldorado Gold
EGO
$9.89B
| $8.69M | ﹤0.01% |
517,028
+1,040
| +0.2% | +$15.6K |
|
|
RDFN
2019
DELISTED
Redfin
RDFN
| $8.67M | ﹤0.01% |
941,621
-80,284
| -8% | -$686K |
|
|
AAMI
2020
Acadian Asset Management
AAMI
$3.2B
| $8.66M | ﹤0.01% |
334,701
-58,653
| -15% | -$1.47M |
|
2021
IAMGOLD
IAG
$10.6B
| $8.65M | ﹤0.01% |
1,385,615
-199,431
| -13% | -$1.18M |
|
2022
SolarEdge
SEDG
$1.95B
| $8.64M | ﹤0.01% |
533,758
+12,830
| +2% | +$200K |
|
2023
Novavax
NVAX
$1.31B
| $8.62M | ﹤0.01% |
1,345,140
-20,274
| -1% | -$168K |
|
2024
Sturm, Ruger & Co
RGR
$593M
| $8.61M | ﹤0.01% |
219,061
+26,660
| +14% | +$1M |
|
2025
Kelly Services Class A
KELYA
$527M
| $8.56M | ﹤0.01% |
650,134
+136,392
| +27% | +$1.86M |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.